Thermo Fisher Scientific (TMO) Change in Receivables (2009 - 2020)

Thermo Fisher Scientific (TMO) has reported Change in Receivables for 12 consecutive years, with $444.0 million the latest figure, recorded in Q4 2020.

• For the quarter ending Q4 2020, Change in Receivables rose 562.5% year-over-year to $444.0 million; the trailing twelve-month figure through Dec 2020 stood at $1.3 billion (up 478.67% YoY), and the FY2025 full-year result was $426.0 million, up 149.12% from the prior year.
• Change in Receivables eased to $444.0 million in Q4 2020 per TMO's latest filing, from $663.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $663.0 million in Q3 2020 and bottomed at -$96.0 million in Q4 2019.
• Historically, Change in Receivables has averaged $130.4 million across 5 years, with a median of $49.6 million in 2016.
• The sharpest annual moves came in 2016 and 2019: Change in Receivables jumped 7629.03% in 2016, then tumbled 230.77% in 2019.
• Over 5 years, Change in Receivables stood at $239.6 million in 2016, then retreated by 16.11% to $201.0 million in 2017, then surged by 50.25% to $302.0 million in 2018, then slumped by 131.79% to -$96.0 million in 2019, then soared by 562.5% to $444.0 million in 2020.
• According to Business Quant data, Change in Receivables over the past three periods registered $444.0 million, $663.0 million, and -$23.0 million for Q4 2020, Q3 2020, and Q2 2020 respectively.